These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38057180)

  • 41. Early assessment of shear wave elastography parameters foresees the response to neoadjuvant chemotherapy in patients with invasive breast cancer.
    Gu J; Polley EC; Denis M; Carter JM; Pruthi S; Gregory AV; Boughey JC; Fazzio RT; Fatemi M; Alizad A
    Breast Cancer Res; 2021 Apr; 23(1):52. PubMed ID: 33926522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of Residual Axillary Nodal Metastasis Following Neoadjuvant Chemotherapy for Breast Cancer: Radiomics Analysis Based on Chest Computed Tomography.
    Lee HJ; Nguyen AT; Song MW; Lee JE; Park SB; Jeong WG; Park MH; Lee JS; Park I; Lim HS
    Korean J Radiol; 2023 Jun; 24(6):498-511. PubMed ID: 37271204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer.
    Kim R; Chang JM; Lee HB; Lee SH; Kim SY; Kim ES; Cho N; Moon WK
    Radiology; 2019 Oct; 293(1):49-57. PubMed ID: 31407967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
    Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
    Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An ultrasound-based nomogram model in the assessment of pathological complete response of neoadjuvant chemotherapy in breast cancer.
    Liu J; Leng X; Liu W; Ma Y; Qiu L; Zumureti T; Zhang H; Mila Y
    Front Oncol; 2024; 14():1285511. PubMed ID: 38500656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiomic signatures derived from multiparametric MRI for the pretreatment prediction of response to neoadjuvant chemotherapy in breast cancer.
    Bian T; Wu Z; Lin Q; Wang H; Ge Y; Duan S; Fu G; Cui C; Su X
    Br J Radiol; 2020 Nov; 93(1115):20200287. PubMed ID: 32822542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of 3D and 2D shear-wave elastography for differentiating benign and malignant breast masses: focus on the diagnostic performance.
    Choi HY; Sohn YM; Seo M
    Clin Radiol; 2017 Oct; 72(10):878-886. PubMed ID: 28526455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination of Quantitative Parameters of Shear Wave Elastography and Superb Microvascular Imaging to Evaluate Breast Masses.
    Lee EJ; Chang YW
    Korean J Radiol; 2020 Sep; 21(9):1045-1054. PubMed ID: 32691540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy.
    Sutton EJ; Onishi N; Fehr DA; Dashevsky BZ; Sadinski M; Pinker K; Martinez DF; Brogi E; Braunstein L; Razavi P; El-Tamer M; Sacchini V; Deasy JO; Morris EA; Veeraraghavan H
    Breast Cancer Res; 2020 May; 22(1):57. PubMed ID: 32466777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The longitudinal changes in multiparametric MRI during neoadjuvant chemotherapy can predict treatment response early in patients with HER2-positive breast cancer.
    Chen S; Zheng B; Tang W; Ding S; Sui Y; Yu X; Zhong Z; Kong Q; Liu W; Guo Y
    Eur J Radiol; 2024 Sep; 178():111656. PubMed ID: 39098252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic Performance of Strain and Shear Wave Elastography for the Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: Systematic Review and Meta-Analysis.
    Jin J; Liu YH; Zhang B
    J Ultrasound Med; 2022 Oct; 41(10):2459-2466. PubMed ID: 34967455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Choudhery S; Gomez-Cardona D; Favazza CP; Hoskin TL; Haddad TC; Goetz MP; Boughey JC
    Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S145-S154. PubMed ID: 33160859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive value of ultrasound doppler parameters in neoadjuvant chemotherapy response of breast cancer: Prospective comparison with magnetic resonance and mammography.
    Conz L; Jales RM; Dória MT; Melloni I; Cres Lyrio CA; Menossi C; Derchain S; Sarian LO
    PLoS One; 2024; 19(6):e0302527. PubMed ID: 38833499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative ultrasound radiomics for therapy response monitoring in patients with locally advanced breast cancer: Multi-institutional study results.
    Quiaoit K; DiCenzo D; Fatima K; Bhardwaj D; Sannachi L; Gangeh M; Sadeghi-Naini A; Dasgupta A; Kolios MC; Trudeau M; Gandhi S; Eisen A; Wright F; Look-Hong N; Sahgal A; Stanisz G; Brezden C; Dinniwell R; Tran WT; Yang W; Curpen B; Czarnota GJ
    PLoS One; 2020; 15(7):e0236182. PubMed ID: 32716959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasound Strain Elastography and Contrast-Enhanced Ultrasound in Predicting the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: A Nomogram Integrating Ki-67 and Ultrasound Features.
    Liu Q; Tang L; Chen M
    J Ultrasound Med; 2022 Sep; 41(9):2191-2201. PubMed ID: 34888900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous comparison between strain and shear wave elastography of breast masses for the differentiation of benign and malignant lesions by qualitative and quantitative assessments.
    Fujioka T; Mori M; Kubota K; Kikuchi Y; Katsuta L; Kasahara M; Oda G; Ishiba T; Nakagawa T; Tateishi U
    Breast Cancer; 2019 Nov; 26(6):792-798. PubMed ID: 31175605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter study.
    Chen H; Zhang X; Wang X; Quan X; Deng Y; Lu M; Wei Q; Ye Q; Zhou Q; Xiang Z; Liang C; Yang W; Zhao Y
    Eur Radiol; 2021 Oct; 31(10):7913-7924. PubMed ID: 33825032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Value of radiomics based on CE-MRI for predicting the efficacy of neoadjuvant chemotherapy in invasive breast cancer.
    Li Q; Huang Y; Xiao Q; Duan S; Wang S; Li J; Niu Q; Gu Y
    Br J Radiol; 2022 Oct; 95(1139):20220186. PubMed ID: 36005646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of pathological complete response after neoadjuvant chemotherapy for breast cancer: comparison of greyscale ultrasound, shear wave elastography, and MRI.
    Evans A; Whelehan P; Thompson A; Purdie C; Jordan L; Macaskill J; Henderson S; Vinnicombe S
    Clin Radiol; 2018 Oct; 73(10):910.e1-910.e6. PubMed ID: 29980324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intra and peritumoral PET radiomics analysis to predict the pathological response in breast cancer patients receiving neoadjuvant chemotherapy.
    Aksu A; Güç ZG; Küçüker KA; Alacacıoğlu A; Turgut B
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(3):500002. PubMed ID: 38527731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.